Search papers, labs, and topics across Lattice.
OncoAgent, a novel AI agent, is introduced to automate clinical target volume (CTV) delineation in radiotherapy by converting textual clinical guidelines into 3D contours without training. The agent achieves zero-shot Dice scores of 0.842 and 0.880 for CTV and planning target volume, respectively, comparable to a fully supervised nnU-Net on esophageal cancer cases. Blinded clinical evaluations showed physicians preferred OncoAgent due to its superior guideline compliance, reduced modification effort, and higher clinical acceptability, with the framework generalizing to alternative guidelines and anatomical sites.
Forget retraining: this guideline-aware AI agent instantly adapts to new radiotherapy protocols, outperforming supervised models in clinical preference.
Delineating the clinical target volume (CTV) in radiotherapy involves complex margins constrained by tumor location and anatomical barriers. While deep learning models automate this process, their rigid reliance on expert-annotated data requires costly retraining whenever clinical guidelines update. To overcome this limitation, we introduce OncoAgent, a novel guideline-aware AI agent framework that seamlessly converts textual clinical guidelines into three-dimensional target contours in a training-free manner. Evaluated on esophageal cancer cases, the agent achieves a zero-shot Dice similarity coefficient of 0.842 for the CTV and 0.880 for the planning target volume, demonstrating performance highly comparable to a fully supervised nnU-Net baseline. Notably, in a blinded clinical evaluation, physicians strongly preferred OncoAgent over the supervised baseline, rating it higher in guideline compliance, modification effort, and clinical acceptability. Furthermore, the framework generalizes zero-shot to alternative esophageal guidelines and other anatomical sites (e.g., prostate) without any retraining. Beyond mere volumetric overlap, our agent-based paradigm offers near-instantaneous adaptability to alternative guidelines, providing a scalable and transparent pathway toward interpretability in radiotherapy treatment planning.
